BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 4, 2013
View Archived Issues
SK Chemical advances influenza vaccine into phase III development
Read More
Improved antiplatelet therapy for the novel P2Y1 blocker BMS-884775
Read More
Researchers in Hungary present novel chimeric fusion proteins for cancer
Read More
Takeda Pharmaceutical presents new agents for diabetes
Read More
Merck & Co. discloses new DPP IV inhibitors
Read More
Scientists at Siga Technologies synthesize novel agents for viral infections
Read More
New CYP11B2/CYP11B1 inhibitors patented by Roche
Read More
GSK receives European marketing authorization for Tafinlar
Read More
First launch of Marqibo in the U.S.
Read More
Amgen begins first-in-human study of AMG-282
Read More
Topline results from phase II ETC-1002 trial reported
Read More
Investigators begin phase I trial of ONT-380 in combination with trastuzumab
Read More
Extract from Calendula officinalis flowers improves memory, learning and attention in rodents
Read More
Tetraphase begins phase III trial of eravacycline in complicated intra-abdominal infections
Read More
Santhera Pharmaceuticals agrees with Takeda to license back European rights to Catena
Read More
Siltuximab applications submitted to FDA and EMA for multicentric Castleman disease
Read More
Zalicus completes patient enrollment in two phase II studies of Z-160
Read More
Novartis receives E.U. approval for Ilaris in active systemic juvenile idiopathic arthritis
Read More
Sanwa Kagaku Kenkyusho announces first launch of topiroxostat in Japan
Read More
Microsphere-encapsulated antagomir-92a shows promise in animal models of MI
Read More
GSK files application in Japan seeking approval for tenofovir in chronic hepatitis B
Read More
Imaxio reports on first human trial using IMX-313 in tuberculosis
Read More
TRAVERSE study of Pexa-Vec in advanced liver cancer fails to meet primary endpoint
Read More
Shionogi launches Irtra in Japan
Read More
Researchers present results from phase III SERAPHIN trial
Read More
Elan begins phase IIa study of ELND-005 for Down syndrome
Read More